Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease

Miranda Orr, Mitzi Gonzales, Valentina Garbarino, Tiffany Kautz, Juan Palavicini, Marisa Lopez-Cruzan, Shiva Kazempour Dehkordi, Julia Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald Petersen, Tamara Tchkonia, James Kirkland, Arash Salardini, Sudha Seshadri, Nicolas Musi

Producción científica: Articlerevisión exhaustiva

Huella

Profundice en los temas de investigación de 'Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science